| Literature DB >> 7125602 |
W Roos, P Huber, L Oeze, U Eppenberger.
Abstract
Conditions are described which allow to demonstrate estradiol dependency of proliferation in MCF-7 human mammary carcinoma cells in a reproducible manner. Our results concerning the action of Tamoxifen on the growth of MCF-7 cells differ in two aspects from previous reports: (a) The inhibitory effect of pharmacological doses (10(-7) M) is only obvious if the cells are stimulated by estradiol. (b) In the absence of estradiol, Tamoxifen acts as a weak estrogenic agonist, by stimulating the growth of MCF-7 cells. This finding could imply that premenopausal women should not be treated with Tamoxifen after ovariectomy.Entities:
Mesh:
Substances:
Year: 1982 PMID: 7125602
Source DB: PubMed Journal: Anticancer Res ISSN: 0250-7005 Impact factor: 2.480